Renal Cell Carcinoma Clinical Roundup

News Articles

Cryoablation Comparable to Surgery for Treating Early-stage Kidney Cancer

(RSNA) June 9, 2020 - Freezing cancer cells in early-stage kidney cancer offers similar results as surgery with lower risks of complications.

Study Reveals Factors Influencing Outcomes In Kidney Cancer Treated With Immunotherapy

(Dana-Farber) May 29, 2020 - By analyzing tumors from patients treated with immunotherapy for advanced kidney cancer in three clinical trials, Dana-Farber Cancer Institute scientists have identified several features of the tumors that influence their response to immune checkpoint inhibitor drugs.

AVEO Oncology Announces TIVO-3 Final Overall Survival Results Featured at ASCO 2020 Virtual Scientific Program and Submitted to U.S. FDA as Part of NDA Filing

(Yahoo! Finance) May 29, 2020 - AVEO Oncology today announced the presentation of results from the final analysis of overall survival (OS) in its pivotal Phase 3 TIVO-3 trial comparing tivozanib, the Company’s next-generation vascular endothelial growth factor (VEGF) receptor tyrosine kinase inhibitor (TKI), to sorafenib in 3rd and 4th...

Novel Targeted Drug Induced Positive Response For Patients With Von Hippel-lindau Disease–associated Kidney Cancer

(MD Anderson) May 28, 2020 - In an international trial led by researchers at The University of Texas MD Anderson Cancer Center, treatment with MK-6482, the small molecule inhibitor of hypoxia-inducible factor (HIF)-2a was well tolerated and resulted in clinical responses for patients with von Hippel-Lindau disease (VHL)–associated...

View all renal cell carcinomca (rcc) cancer news

Publications

Optimizing patient selection for cytoreductive nephrectomy based on outcomes in the contemporary era of systemic therapy

(Cancer) - 2020-06-10

Salvage Ipilimumab and Nivolumab in Patients With Metastatic Renal Cell Carcinoma After Prior Immune Checkpoint Inhibitors

(Journal of clinical oncology : official journal of the American Society of Clinical Oncology) - 2020-06-04

Evaluation of the Safety and Efficacy of Immunotherapy Rechallenge in Patients With Renal Cell Carcinoma

(JAMA oncology) - 2020-05-30

Efficacy of Savolitinib vs Sunitinib in Patients With MET-Driven Papillary Renal Cell Carcinoma: The SAVOIR Phase 3 Randomized Clinical Trial

(JAMA oncology) - 2020-05-30

Podcasts

Renal Cell Carcinoma (RCC) – Tian Zhang, MD, and Robert Figlin, MD, discuss recent clinical advances in RCC from ASCO GU

Robert Figlin, MD, Steven Spielberg Family Chair in Hematology-Oncology, Cedars-Sinai Medical Center, and Tian Zhang, MD, Assistant Professor of Medicine, Duke University School of Medicine, discuss the progress in RCC presented at ASCO GU '20